Severe Lymphopenia after Chemoradiation Treatment is Associated with Worse Survival in Patients with Newly Diagnosed GBM

被引：0
|
作者：
Song, A. J. [1 ]
Gowda, S. [2 ]
Kim, L. [3 ]
Werner-Wasik, M. [1 ]
Andrews, D. W. [3 ]
Glass, J. [3 ]
Judy, K. [3 ]
Farrell, C. [3 ]
Shi, W. [1 ]
机构：
[1] Thomas Jefferson Univ, Dept Radiat Oncol, Sidney Kimmel Canc Ctr, Philadelphia, PA 19107 USA
[2] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA
[3] Thomas Jefferson Univ Hosp, Dept Neurosurg, Philadelphia, PA 19107 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2018年 / 102卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2018.07.1050
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MO_36_2806
引用
收藏
页码：E345 / E345
页数：1
相关论文
共 50 条
  • [1] Survival in Patients With Severe Lymphopenia Following Treatment With Radiation and Chemotherapy for Newly Diagnosed Solid Tumors
    Grossman, Stuart A.
    Ellsworth, Susannah
    Campian, Jian
    Wild, Aaron T.
    Herman, Joseph M.
    Laheru, Dan
    Brock, Malcolm
    Balmanoukian, Ani
    Ye, Xiaobu
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2015, 13 (10): : 1225 - 1231
  • [2] Severe Treatment-Related Lymphopenia in Patients with Newly Diagnosed Rectal Cancer
    Campian, Jian L.
    Ye, Xiaobu
    Sarai, Guneet
    Herman, Joseph
    Grossman, Stuart A.
    CANCER INVESTIGATION, 2018, 36 (06) : 356 - 361
  • [3] Effect of treatment-related lymphopenia on survival in newly diagnosed patients with resected adenocarcinoma of the pancreas
    Balmanoukian, Ani Sarkis
    Ye, Xiaobu
    Herman, Joseph M.
    Laheru, Dan
    Grossman, Stuart A.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [4] Chemoradiation Treatment with or without Concurrent Tumor-Treating Fields (TTFields) in Patients with Newly Diagnosed Glioblastoma (GBM)
    Cappelli, L.
    Kanyne, A.
    Pan, P. C.
    Cordova, J. S.
    Huang, J.
    Wang, T. J. C.
    Alnahhas, I.
    Shi, W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E68 - E68
  • [5] Chemoradiation-Related Lymphopenia Is Common Among Glioblastoma Patients and Is Associated With Worse Progression-Free and Overall Survival
    Rahman, R.
    Catalano, P. J.
    Arvold, N. D.
    Aizer, A. A.
    Weiss, S. E.
    Pinnell, N.
    Horvath, M. C.
    Christianson, L.
    Reardon, D. A.
    Lee, E. Q.
    Nayak, L.
    Rinne, M.
    Dunn, I. F.
    Golby, A. J.
    Johnson, M. D.
    Claus, E. B.
    Ligon, K. L.
    Wen, P.
    Alexander, B. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E123 - E123
  • [6] Evaluation of pre-treatment mr markers that predict survival in patients with newly diagnosed GBM
    Saraswathy, Suja
    Crawford, Forrest
    Lamborn, Kathleen
    Pirzkall, Andrea
    Chang, Susan
    Cha, Soonmee
    Nelson, Sarah
    NEURO-ONCOLOGY, 2007, 9 (04) : 574 - 574
  • [7] Association between treatment-related lymphopenia and overall survival in elderly patients with newly diagnosed glioblastoma
    Mendez, Joe S.
    Govindan, Ashwin
    Leong, Jacqueline
    Gao, Feng
    Huang, Jiayi
    Campian, Jian L.
    JOURNAL OF NEURO-ONCOLOGY, 2016, 127 (02) : 329 - 335
  • [8] CHEMORADIATION (CRT) TREATMENT WITH OR WITHOUT CONCURRENT TUMOR-TREATING FIELDS (TTFIELDS) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Cappelli, Louis
    Kayne, Allison
    Pan, Peter
    Cordova, James
    Huang, Jiayi
    Wang, Tony
    Alnahhas, Iyad
    Shi, Wenyin
    NEURO-ONCOLOGY, 2022, 24 : 53 - 53
  • [9] Association between treatment-related lymphopenia and overall survival in elderly patients with newly diagnosed glioblastoma
    Joe S. Mendez
    Ashwin Govindan
    Jacqueline Leong
    Feng Gao
    Jiayi Huang
    Jian L. Campian
    Journal of Neuro-Oncology, 2016, 127 : 329 - 335
  • [10] The Association Between Treatment-Related Lymphopenia and Survival in Newly Diagnosed Patients with Resected Adenocarcinoma of the Pancreas
    Balmanoukian, Ani
    Ye, Xiaobu
    Herman, Joseph
    Laheru, Daniel
    Grossman, Stuart A.
    CANCER INVESTIGATION, 2012, 30 (08) : 571 - 576
12345